[Surgical Treatment of Focal Cartilage Defects in the Knee : Indications, Techniques, Modifications and Results]

Overview

Journal Orthopade

Specialty Orthopedics

Date 2022 Jan 25

PMID 35076725

Authors

S Anders

J Grifka

Affiliations

Soon will be listed here.

Abstract

The treatment strategies for focal cartilage damage in the knee are multifarious. For established procedures, such as microfracturing (MFX), autologous matrix-induced chondrogenesis (AMIC), osteochondral transplantation (OCT) and autologous chondrocyte transplantation (ACT), well-founded, partly comparative long-term studies and overlapping size-dependent differential indications are available. Innovative cell sources, the utilization of biological scaffolds as well as biologic agents and various combinations, have recently become the focus of scientific attention; however, high regulatory demands are restricting their use in Germany. The success of every procedure is dependent on the appropriate indications, the treatment of comorbidities, such as axis deviations or ligamentous instability, the surgeon's experience and an adequate follow-up treatment.

References

Widuchowski W, Widuchowski J, Trzaska T . Articular cartilage defects: study of 25,124 knee arthroscopies. Knee. 2007; 14(3):177-82. DOI: 10.1016/j.knee.2007.02.001. View

Brittberg M, Winalski C . Evaluation of cartilage injuries and repair. J Bone Joint Surg Am. 2003; 85-A Suppl 2:58-69. DOI: 10.2106/00004623-200300002-00008. View

DellAccio F, Vincent T . Joint surface defects: clinical course and cellular response in spontaneous and experimental lesions. Eur Cell Mater. 2010; 20:210-7. DOI: 10.22203/ecm.v020a17. View

DiBartola A, Everhart J, Magnussen R, Carey J, Brophy R, Schmitt L . Correlation between histological outcome and surgical cartilage repair technique in the knee: A meta-analysis. Knee. 2016; 23(3):344-9. DOI: 10.1016/j.knee.2016.01.017. View

Riboh J, Cvetanovich G, Cole B, Yanke A . Comparative efficacy of cartilage repair procedures in the knee: a network meta-analysis. Knee Surg Sports Traumatol Arthrosc. 2016; 25(12):3786-3799. DOI: 10.1007/s00167-016-4300-1. View

Steadman J, Rodkey W, Briggs K, Rodrigo J . [The microfracture technic in the management of complete cartilage defects in the knee joint]. Orthopade. 1999; 28(1):26-32. DOI: 10.1007/s001320050318. View

Steadman J, Briggs K, Rodrigo J, Kocher M, Gill T, Rodkey W . Outcomes of microfracture for traumatic chondral defects of the knee: average 11-year follow-up. Arthroscopy. 2003; 19(5):477-84. DOI: 10.1053/jars.2003.50112. View

Mithoefer K, Williams 3rd R, Warren R, Potter H, Spock C, Jones E . Chondral resurfacing of articular cartilage defects in the knee with the microfracture technique. Surgical technique. J Bone Joint Surg Am. 2006; 88 Suppl 1 Pt 2:294-304. DOI: 10.2106/JBJS.F.00292. View

Gobbi A, Nunag P, Malinowski K . Treatment of full thickness chondral lesions of the knee with microfracture in a group of athletes. Knee Surg Sports Traumatol Arthrosc. 2004; 13(3):213-21. DOI: 10.1007/s00167-004-0499-3. View

10.

Benthien J, Behrens P . Nanofractured autologous matrix induced chondrogenesis (NAMIC©)--Further development of collagen membrane aided chondrogenesis combined with subchondral needling: A technical note. Knee. 2015; 22(5):411-5. DOI: 10.1016/j.knee.2015.06.010. View

11.

Shah S, Lee S, Mithoefer K . Next-Generation Marrow Stimulation Technology for Cartilage Repair: Basic Science to Clinical Application. JBJS Rev. 2021; 9(1):e20.00090. DOI: 10.2106/JBJS.RVW.20.00090. View

12.

Benthien J, Behrens P . The treatment of chondral and osteochondral defects of the knee with autologous matrix-induced chondrogenesis (AMIC): method description and recent developments. Knee Surg Sports Traumatol Arthrosc. 2011; 19(8):1316-9. DOI: 10.1007/s00167-010-1356-1. View

13.

Gille J, Behrens P, Volpi P, de Girolamo L, Reiss E, Zoch W . Outcome of Autologous Matrix Induced Chondrogenesis (AMIC) in cartilage knee surgery: data of the AMIC Registry. Arch Orthop Trauma Surg. 2012; 133(1):87-93. PMC: 3535369. DOI: 10.1007/s00402-012-1621-5. View

14.

Steinwachs M, Gille J, Volz M, Anders S, Jakob R, de Girolamo L . Systematic Review and Meta-Analysis of the Clinical Evidence on the Use of Autologous Matrix-Induced Chondrogenesis in the Knee. Cartilage. 2019; 13(1_suppl):42S-56S. PMC: 8808829. DOI: 10.1177/1947603519870846. View

15.

Minas T, von Keudell A, Bryant T, Gomoll A . The John Insall Award: A minimum 10-year outcome study of autologous chondrocyte implantation. Clin Orthop Relat Res. 2013; 472(1):41-51. PMC: 3889462. DOI: 10.1007/s11999-013-3146-9. View

16.

Kon E, Delcogliano M, Filardo G, Montaperto C, Marcacci M . Second generation issues in cartilage repair. Sports Med Arthrosc Rev. 2008; 16(4):221-9. DOI: 10.1097/JSA.0b013e31818cdbc5. View

17.

Saris D, Vanlauwe J, Victor J, Haspl M, Bohnsack M, Fortems Y . Characterized chondrocyte implantation results in better structural repair when treating symptomatic cartilage defects of the knee in a randomized controlled trial versus microfracture. Am J Sports Med. 2008; 36(2):235-46. DOI: 10.1177/0363546507311095. View

18.

Brittberg M . Cell carriers as the next generation of cell therapy for cartilage repair: a review of the matrix-induced autologous chondrocyte implantation procedure. Am J Sports Med. 2009; 38(6):1259-71. DOI: 10.1177/0363546509346395. View

19.

Welch T, Mandelbaum B, Tom M . Autologous Chondrocyte Implantation: Past, Present, and Future. Sports Med Arthrosc Rev. 2016; 24(2):85-91. DOI: 10.1097/JSA.0000000000000115. View

20.

Bode G, Schmal H, Pestka J, Ogon P, Sudkamp N, Niemeyer P . A non-randomized controlled clinical trial on autologous chondrocyte implantation (ACI) in cartilage defects of the medial femoral condyle with or without high tibial osteotomy in patients with varus deformity of less than 5°. Arch Orthop Trauma Surg. 2012; 133(1):43-9. DOI: 10.1007/s00402-012-1637-x. View